FDA Responds To Coronavirus By Getting Out First Emergency-Use Novel Coronavirus Diagnostic

The US agency on 4 February issued its first Emergency Use Authorization of a 2019-novel coronavirus test by enabling emergency use of the Centers for Disease Control and Prevention’s 2019-nCoV Real-Time RT-PCR Diagnostic Panel. The move will allow use of the test at any CDC-qualified lab across the US.

Coronavirus disease and flu outbreak or coronaviruses influenza background as dangerous viral strain case as a pandemic medical health risk concept with dangerous cells as a 3D render

The US Food and Drug Administration on 4 February gave its stamp of approval under its Emergency Use Authorization (EUA) process to a 2019-novel coronavirus test that was developed and already in use by Centers for Disease Control and Prevention (CDC) laboratories.

The authorization permits any CDC-qualified state or local laboratory in the US to apply the RT-PCR diagnostic assay to newly...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from In Vitro Diagnostics

More from Diagnostics